Linde Plc (LIN) Stock Analysis and Metrics

Sector: Basic Materials Industry: Specialty Chemicals CIK: 0001707925

Market Cap 230.79 Bn

P/E 32.83

P/S 6.66

Div. Yield 0.01

ROIC (Qtr) 0.00

Total Debt (Qtr) 24.68 Bn

Revenue Growth (1y) (Qtr) 8.25

Add ratio to table...

About

Linde plc is the largest industrial gas company worldwide and a major technological innovator in the industrial gases industry. Its primary products include atmospheric gases such as oxygen, nitrogen, argon, and rare gases, and process gases such as hydrogen, helium, carbon dioxide, carbon monoxide, electronic gases, specialty gases, and acetylene. The company also designs and builds equipment that produces industrial gases and offers customers a wide range of gas production and processing services, including olefin plants, natural gas plants, air...

Linde plc is the largest industrial gas company worldwide and a major technological innovator in the industrial gases industry. Its primary products include atmospheric gases such as oxygen, nitrogen, argon, and rare gases, and process gases such as hydrogen, helium, carbon dioxide, carbon monoxide, electronic gases, specialty gases, and acetylene. The company also designs and builds equipment that produces industrial gases and offers customers a wide range of gas production and processing services, including olefin plants, natural gas plants, air separation plants, hydrogen and synthesis gas plants, and other types of plants. Linde serves a diverse group of industries including healthcare, chemicals and energy, manufacturing, metals and mining, food and beverage, and electronics.

Linde generates revenue primarily from the sale of its industrial gases and related equipment and services. Its core revenue streams come from supplying atmospheric and process gases to industrial customers and from engineering contracts for the design and construction of gas production and processing facilities. In 2025 the company recorded sales of $33,986 million, in 2024 sales were $33,005 million, and in 2023 sales were $32,854 million. Revenue is derived from a broad customer base across multiple sectors, reducing reliance on any single industry or client.

The company operates through the following segments: Industrial Gases and Engineering.

• Industrial Gases: This segment produces atmospheric gases including oxygen, nitrogen, argon, and rare gases, and process gases such as hydrogen, helium, carbon dioxide, carbon monoxide, electronic gases, specialty gases, and acetylene. It also designs and builds gas production equipment and offers related services such as olefin, natural gas, air separation, and hydrogen and synthesis gas plants. The segment distributes gases through on site, merchant bulk liquid, and packaged cylinder methods to serve industries including healthcare, chemicals and energy, manufacturing, metals and mining, food and beverage, and electronics.

• Engineering: This segment focuses on market segments such as air separation, hydrogen, synthesis, and olefin and natural gas plants. It uses process engineering expertise to plan, design, and construct efficient plants for the production and processing of gases. The segment employs sustainable technologies to help customers avoid, capture, and utilize carbon dioxide emissions. Its technology portfolio covers the entire value chain for production, liquefaction, storage, distribution, and application of hydrogen, supporting the transition to clean energy. Digital services and solutions are provided to increase plant efficiency and performance. Engineering supplies plant components directly to customers or to Linde’s industrial gas business, which operates the plants under long term gas supply contracts. The segment’s plants are used in petrochemical and chemical industries, refineries, fertilizer plants, to recover air gases, to produce synthesis gases, to treat natural gas, and to produce noble gases.

Linde holds the leading position in the global industrial gases market as the largest producer by volume. Its main competitors include L’Air Liquide S. A., Air Products and Chemicals, Inc., Messer Group GmbH, and Mitsubishi Chemical Holdings Corporation through its Taiyo Nippon Sanso subsidiary, along with numerous small to medium independent regional players. A key competitive advantage derives from its extensive pipeline networks that enable reliable and economic supply to large volume customers. The company also benefits from its technological leadership in non cryogenic air separation and in low carbon hydrogen production methods.

Linde serves a broad customer base that spans multiple industries including healthcare providers, chemical manufacturers, refineries, metal producers, food and beverage processors, and electronics manufacturers. The company’s customers range from hospitals requiring medical gases to large industrial complexes needing bulk oxygen, nitrogen, and hydrogen for production processes. While specific customer names are not disclosed in the filing, the diversified mix reduces dependence on any single client or sector.

Investment thesis

Bull case

Linde’s record $10 billion project backlog, excluding the $500 million in space‑related contracts, demonstrates a robust pipeline that will translate into 2.5–3 billion of revenue contributions in 2026. The company’s engineering and project‑startup efficiencies, highlighted by the 29.5% operating margin in Q4, suggest that backlog conversion rates are already exceeding historical averages. With aggressive capital deployment focused on high‑density gas facilities in Texas and Florida, Linde is positioning itself to capture a larger share of the projected 10‑plus percent growth in global launch activity. The resulting scale advantages will likely drive further price discipline and margin expansion above the long‑term 30–50 basis‑point range, reinforcing investor confidence in the company’s cost discipline. {bullet} The oxyfuel technology wins, exceeding 90 new contracts in 2025 and concentrating heavily in China, represent a high‑margin, high‑penetration opportunity that aligns with global decarbonization mandates. By enabling customers to reduce natural‑gas consumption and emissions while increasing throughput, these wins are expected to generate significant incremental cash flow that can be reinvested in back‑to‑back projects. The geographic diversity of these contracts mitigates country‑specific risk, while the strong demand in emerging markets such as India and ASEAN suggests a durable growth engine. As regulatory pressures intensify, Linde’s oxyfuel portfolio is likely to command premium pricing, further bolstering profitability. {bullet} Linde’s disciplined capital allocation, returning over $7 billion to shareholders in 2025 and projecting $5.0–5.5 billion in 2026 CapEx, illustrates a mature, shareholder‑friendly model that balances growth and value creation. The firm’s 24.2% return on capital remains well above the industrial gas industry average, indicating efficient use of invested capital and a healthy buffer for weathering macro‑economic swings. Share repurchases, buoyed by attractive share price and strong free‑cash flow, add a layer of upside for equity holders and signal management confidence in the firm’s intrinsic value. {bullet} The company’s low‑carbon progress, with 50% of its power consumption sourced from low‑carbon energy and a reduction of nearly 2 million metric tons of CO₂, positions Linde favorably amid increasing ESG scrutiny. This trajectory aligns with long‑term policy trends favoring green gas solutions and positions Linde to capture new revenue streams from clean‑hydrogen and carbon‑capture customers. The demonstrated ability to scale sustainable operations without compromising margins underscores operational resilience. {bullet} Linde’s presence in the commercial space sector, where it supplies 65–75% of global launches, is expected to deliver double‑digit growth over the next few years. The strategic investment in launch‑capable facilities and the pipeline of contracts with major launch customers such as SpaceX and Arianespace signal a secular shift toward a high‑margin, high‑frequency business. As the launch market expands to support the burgeoning satellite constellation and human‑spaceflight initiatives, Linde is well‑positioned to capture a growing share of the high‑purity gas demand inherent to these operations. {bullet} The company’s management expressed guarded confidence about 2026 guidance, yet the underlying data—projected 6–9% EPS growth, $10 billion backlog, and disciplined pricing—suggests that the market is likely underestimating the upside. By setting a conservative base‑volume assumption of 0% while still projecting strong revenue growth, management is signaling a potential upside scenario if macro‑economic conditions improve. The company’s historical track record of achieving pricing targets in line with inflation further supports a bullish outlook. {bullet} The synergy realization from the $400 million bolt‑on acquisitions completed in 2025, expected to reach 1% of sales, demonstrates Linde’s capacity to generate incremental revenue and margin enhancement through strategic acquisitions. With a 12–24 month window for full‑run‑rate synergy realization, these deals will likely contribute to both top‑line and bottom‑line growth in 2026, enhancing shareholder returns. This disciplined acquisition strategy complements organic growth initiatives, providing a balanced growth engine. {bullet} Finally, Linde’s leadership stability, with CEO Sanjiv Lamba’s decade‑long tenure and a clear six‑point growth blueprint, reinforces strategic continuity. The firm’s transparent communication, disciplined pricing discipline, and focus on high‑quality wins signal a strong governance culture that investors can trust. Given the company’s track record of outperforming peers in a cyclical industry, the bullish thesis highlights significant upside potential that the market may have overlooked.

Linde’s record $10 billion project backlog, excluding the $500 million in space‑related contracts, demonstrates a robust pipeline that will translate into 2.5–3 billion of revenue contributions in 2026. The company’s engineering and project‑startup efficiencies, highlighted by the 29.5% operating margin in Q4, suggest that backlog conversion rates are already exceeding historical averages. With aggressive capital deployment focused on high‑density gas facilities in Texas and Florida, Linde is positioning itself to capture a larger share of the projected 10‑plus percent growth in global launch activity. The resulting scale advantages will likely drive further price discipline and margin expansion above the long‑term 30–50 basis‑point range, reinforcing investor confidence in the company’s cost discipline. {bullet} The oxyfuel technology wins, exceeding 90 new contracts in 2025 and concentrating heavily in China, represent a high‑margin, high‑penetration opportunity that aligns with global decarbonization mandates. By enabling customers to reduce natural‑gas consumption and emissions while increasing throughput, these wins are expected to generate significant incremental cash flow that can be reinvested in back‑to‑back projects. The geographic diversity of these contracts mitigates country‑specific risk, while the strong demand in emerging markets such as India and ASEAN suggests a durable growth engine. As regulatory pressures intensify, Linde’s oxyfuel portfolio is likely to command premium pricing, further bolstering profitability. {bullet} Linde’s disciplined capital allocation, returning over $7 billion to shareholders in 2025 and projecting $5.0–5.5 billion in 2026 CapEx, illustrates a mature, shareholder‑friendly model that balances growth and value creation. The firm’s 24.2% return on capital remains well above the industrial gas industry average, indicating efficient use of invested capital and a healthy buffer for weathering macro‑economic swings. Share repurchases, buoyed by attractive share price and strong free‑cash flow, add a layer of upside for equity holders and signal management confidence in the firm’s intrinsic value. {bullet} The company’s low‑carbon progress, with 50% of its power consumption sourced from low‑carbon energy and a reduction of nearly 2 million metric tons of CO₂, positions Linde favorably amid increasing ESG scrutiny. This trajectory aligns with long‑term policy trends favoring green gas solutions and positions Linde to capture new revenue streams from clean‑hydrogen and carbon‑capture customers. The demonstrated ability to scale sustainable operations without compromising margins underscores operational resilience. {bullet} Linde’s presence in the commercial space sector, where it supplies 65–75% of global launches, is expected to deliver double‑digit growth over the next few years. The strategic investment in launch‑capable facilities and the pipeline of contracts with major launch customers such as SpaceX and Arianespace signal a secular shift toward a high‑margin, high‑frequency business. As the launch market expands to support the burgeoning satellite constellation and human‑spaceflight initiatives, Linde is well‑positioned to capture a growing share of the high‑purity gas demand inherent to these operations. {bullet} The company’s management expressed guarded confidence about 2026 guidance, yet the underlying data—projected 6–9% EPS growth, $10 billion backlog, and disciplined pricing—suggests that the market is likely underestimating the upside. By setting a conservative base‑volume assumption of 0% while still projecting strong revenue growth, management is signaling a potential upside scenario if macro‑economic conditions improve. The company’s historical track record of achieving pricing targets in line with inflation further supports a bullish outlook. {bullet} The synergy realization from the $400 million bolt‑on acquisitions completed in 2025, expected to reach 1% of sales, demonstrates Linde’s capacity to generate incremental revenue and margin enhancement through strategic acquisitions. With a 12–24 month window for full‑run‑rate synergy realization, these deals will likely contribute to both top‑line and bottom‑line growth in 2026, enhancing shareholder returns. This disciplined acquisition strategy complements organic growth initiatives, providing a balanced growth engine. {bullet} Finally, Linde’s leadership stability, with CEO Sanjiv Lamba’s decade‑long tenure and a clear six‑point growth blueprint, reinforces strategic continuity. The firm’s transparent communication, disciplined pricing discipline, and focus on high‑quality wins signal a strong governance culture that investors can trust. Given the company’s track record of outperforming peers in a cyclical industry, the bullish thesis highlights significant upside potential that the market may have overlooked.

Bear case

Management’s candid admission of broad‑based weakness in EMEA, with no substantive recovery catalyst on the horizon, signals a persistent downside risk to revenue growth. The region’s chemical and energy end markets have delivered negative volume growth, and pricing in Europe remains constrained despite the company’s historically strong price‑setting track record. This geographical imbalance means that even a robust Americas or APAC performance may not fully offset the erosion in the company’s largest revenue region, potentially compressing overall earnings. {bullet} Helium and rare‑gas pricing continued to deliver a 1–2% headwind to EPS in 2025, and management has explicitly stated no change is expected for 2026. Given that helium represents a low‑margin, high‑volume business, any persistent oversupply could erode pricing power and margin expansion efforts. The company’s other “other” segment, which includes helium intercompany sales, remains a drag on operating income and could limit the overall profitability of the gas business. {bullet} The company’s 2026 base‑volume guidance of 0% underscores a guarded outlook on macro‑economic conditions, and management explicitly describes the guidance language as “guarded, prudent, and conservative.” This cautious stance indicates that growth expectations are highly dependent on favorable macro‑economic outcomes that remain uncertain. Should a downturn in industrial activity or a slowdown in key end markets materialize, the company’s top‑line growth could stall or even contract. {bullet} While the backlog is record‑high, a large portion of it is contingent on project startups that are still under construction. The company disclosed that 2.5–3 billion of projects are expected to start in 2026, yet the conversion rate of backlog to revenue can be highly variable, subject to construction delays, permitting issues, and customer credit risk. Any slowdown in project start‑ups could create a gap between revenue expectations and actual performance, pressuring margins and cash flow. {bullet} Restructuring actions booked at $230 million, while generating cash payback, are structural and focus on headcount reductions in engineering. Although these actions should produce margin uplift in the second half of 2026, they also signal that the company is already operating on a constrained cost base. If macro‑economic headwinds worsen, the company may be forced to further cut costs, which could harm employee morale and execution capability. {bullet} The company’s heavy reliance on capital expenditure—17% higher in Q4 than the prior year and projected 5.0–5.5 billion in 2026—places significant pressure on free cash flow. While operating cash flow exceeded $3 billion in Q4, the CapEx commitment could strain cash reserves if earnings do not grow as projected. Any unexpected capital requirements, such as for additional space‑sector infrastructure or unforeseen project delays, could further compress cash flow and limit the ability to return capital to shareholders. {bullet} Linde’s expansion into the commercial space sector, while a high‑growth opportunity, also introduces concentration risk. The firm supplies 65–75% of global launches, making it highly dependent on a relatively small number of launch customers and launch cadence. Any slowdown in launch activity, increased competition from new entrants, or regulatory changes affecting launch operations could disproportionately impact Linde’s revenue and margin contribution from this segment. {bullet} Finally, the company’s acquisition strategy, though disciplined, is limited to bolt‑on purchases that contribute only 1% to sales in 2025. The time lag to realize synergies—12 to 24 months—means that recent acquisitions may not materially improve profitability in the near term. If the integration process encounters challenges or if target companies underperform, the expected upside from acquisitions could be delayed or reduced, further dampening growth prospects.

Management’s candid admission of broad‑based weakness in EMEA, with no substantive recovery catalyst on the horizon, signals a persistent downside risk to revenue growth. The region’s chemical and energy end markets have delivered negative volume growth, and pricing in Europe remains constrained despite the company’s historically strong price‑setting track record. This geographical imbalance means that even a robust Americas or APAC performance may not fully offset the erosion in the company’s largest revenue region, potentially compressing overall earnings. {bullet} Helium and rare‑gas pricing continued to deliver a 1–2% headwind to EPS in 2025, and management has explicitly stated no change is expected for 2026. Given that helium represents a low‑margin, high‑volume business, any persistent oversupply could erode pricing power and margin expansion efforts. The company’s other “other” segment, which includes helium intercompany sales, remains a drag on operating income and could limit the overall profitability of the gas business. {bullet} The company’s 2026 base‑volume guidance of 0% underscores a guarded outlook on macro‑economic conditions, and management explicitly describes the guidance language as “guarded, prudent, and conservative.” This cautious stance indicates that growth expectations are highly dependent on favorable macro‑economic outcomes that remain uncertain. Should a downturn in industrial activity or a slowdown in key end markets materialize, the company’s top‑line growth could stall or even contract. {bullet} While the backlog is record‑high, a large portion of it is contingent on project startups that are still under construction. The company disclosed that 2.5–3 billion of projects are expected to start in 2026, yet the conversion rate of backlog to revenue can be highly variable, subject to construction delays, permitting issues, and customer credit risk. Any slowdown in project start‑ups could create a gap between revenue expectations and actual performance, pressuring margins and cash flow. {bullet} Restructuring actions booked at $230 million, while generating cash payback, are structural and focus on headcount reductions in engineering. Although these actions should produce margin uplift in the second half of 2026, they also signal that the company is already operating on a constrained cost base. If macro‑economic headwinds worsen, the company may be forced to further cut costs, which could harm employee morale and execution capability. {bullet} The company’s heavy reliance on capital expenditure—17% higher in Q4 than the prior year and projected 5.0–5.5 billion in 2026—places significant pressure on free cash flow. While operating cash flow exceeded $3 billion in Q4, the CapEx commitment could strain cash reserves if earnings do not grow as projected. Any unexpected capital requirements, such as for additional space‑sector infrastructure or unforeseen project delays, could further compress cash flow and limit the ability to return capital to shareholders. {bullet} Linde’s expansion into the commercial space sector, while a high‑growth opportunity, also introduces concentration risk. The firm supplies 65–75% of global launches, making it highly dependent on a relatively small number of launch customers and launch cadence. Any slowdown in launch activity, increased competition from new entrants, or regulatory changes affecting launch operations could disproportionately impact Linde’s revenue and margin contribution from this segment. {bullet} Finally, the company’s acquisition strategy, though disciplined, is limited to bolt‑on purchases that contribute only 1% to sales in 2025. The time lag to realize synergies—12 to 24 months—means that recent acquisitions may not materially improve profitability in the near term. If the integration process encounters challenges or if target companies underperform, the expected upside from acquisitions could be delayed or reduced, further dampening growth prospects.

Geographical Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer comparison

Companies in the Specialty Chemicals

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	LIN	Linde Plc	230.79 Bn	32.83	6.66	24.68 Bn
2	SQM	Chemical & Mining Co Of Chile Inc	127.66 Bn	-54.03	27.90	4.79 Bn
3	SHW	Sherwin Williams Co	72.51 Bn	28.00	3.03	9.32 Bn
4	ECL	Ecolab Inc.	70.96 Bn	34.17	4.41	8.24 Bn
5	APD	Air Products & Chemicals, Inc.	62.15 Bn	29.52	4.99	17.40 Bn
6	PPG	Ppg Industries Inc	25.04 Bn	15.83	1.55	7.14 Bn
7	LYB	LyondellBasell Industries N.V.	21.62 Bn	-31.37	0.73	12.70 Bn
8	ALB	Albemarle Corp	20.26 Bn	-28.12	3.69	1.88 Bn

Research Tools

Developers

Linde Plc (NASDAQ: LIN)

About

Investment thesis

Bull case

Bear case

Geographical Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer comparison

Research Tools

Developers

Linde Plc (NASDAQ: LIN)

About

Investment thesis

Bull case

Bear case

Geographical Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer comparison

Create an account

Sign In

Reset Password